Search Results 171-180 of 16671 for Androgens

  1. Does shaved hair grow back thicker? - Mayo Clinic

    Androgen excess: Investigations and management. Best Practice & Research Clinical Obstetrics & Gynaecology. 2016; doi: https://doi.org/10/106/j.bpobgyn ...

  2. Hematology - Clinical trials

    Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...

  3. Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative To Placebo Plus Abiraterone Plus Prednisone/Prednisolone In Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    Previous treatment with flutamide, steroidal anti-androgens, androgens, estrogens, bicalutamide, nilutamide, or 5-α reductase inhibitor is permitted. In the ...

  4. Publications - Lance C. Pagliaro, M.D. - Mayo Clinic

    Radiographic paradoxical response in metastatic castrate-resistant prostate cancer (mCRPC) managed with new generation anti-androgens: a retrospective analysis.

  5. Publications - Ephraim E. Parent, M.D., Ph.D. - Mayo Clinic

    ... androgens designed to probe the role of sex hormone binding globulin in imaging androgen receptors in prostate tumors by positron emission tomography. J Org ...

  6. Efficacy Of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy - Mayo Clinic

    * Requiring adjuvant radiation therapy or androgen deprivation / androgen blockade post-operatively (by the time of enrollment) * Baseline severe erectile ...

  7. Study To Evaluate 99mTc-MIP-1404 SPECT/CT Imaging In Men With Biopsy Proven Low-Grade Prostate Cancer - Mayo Clinic

    ... androgens, for the treatment of prostate cancer or benign prostatic hyperplasia (BPH); Planned androgen or anti-androgen therapy prior to RP surgery or biopsy ...

  8. S1216, Phase III ADT+TAK-700 Vs. ADT+Bicalutamide For Metastatic Prostate Cancer - Mayo Clinic

    The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation ...

  9. Once-daily Oral VT-464 In Patients With Castration-Resistant Prostate Cancer Progressing On Enzalutamide Or Abiraterone. - Mayo Clinic

    The goal of this clinical study is to determine the safety and efficacy of VT-464, a lyase-selective inhibitor of CYP17 and an androgen receptor antagonist, in ...

  10. Mayo Expert Addresses Bone and Mineral Scientists

    ... androgen. “I see [prostate cancer] patients who urologists treat with androgen-deprivation therapy getting fractures,” says Dr. Khosla. “These patients are ...